Parallax Volatility Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $919K | Sell |
3,654
-13,032
| -78% | -$2.8M | ﹤0.01% | 979 |
|
|
2026
Q1 | $3.42M | Buy |
16,686
+9,251
| +124% | +$2.05M | 0.01% | 673 |
|
|
2025
Q4 | $1.7M | Sell |
7,435
-8,667
| -54% | -$1.97M | ﹤0.01% | 993 |
|
|
2025
Q3 | $3.73M | Buy |
+16,102
| New | +$3.28M | 0.01% | 756 |
|
|
2025
Q2 | – | Sell |
-2
| Closed | -$372 | – | 1529 |
|
|
2025
Q1 | $419 | Sell |
2
-105,071
| -100% | -$20.4M | ﹤0.01% | 1471 |
|
|
2024
Q4 | $18.7M | Buy |
105,073
+60,447
| +135% | +$11.1M | 0.04% | 365 |
|
|
2024
Q3 | $8.81M | Buy |
44,626
+11,432
| +34% | +$2.13M | 0.02% | 597 |
|
|
2024
Q2 | $5.69M | Buy |
33,194
+24,012
| +262% | +$3.98M | 0.01% | 679 |
|
|
2024
Q1 | $1.67M | Buy |
+9,182
| New | +$1.58M | ﹤0.01% | 1083 |
|
|
2023
Q4 | – | Sell |
-28,649
| Closed | -$4.18M | – | 2121 |
|
|
2023
Q3 | $4.27M | Buy |
+28,649
| New | +$4.21M | 0.01% | 819 |
|
|
2023
Q2 | – | Sell |
-33,583
| Closed | -$4.92M | – | 2323 |
|
|
2023
Q1 | $5.35M | Sell |
33,583
-18,169
| -35% | -$2.78M | 0.01% | 833 |
|
|
2022
Q4 | $8.36M | Sell |
51,752
-31,754
| -38% | -$4.87M | 0.01% | 837 |
|
|
2022
Q3 | $11.2M | Buy |
+83,506
| New | +$12M | 0.02% | 731 |
|
|
2020
Q4 | – | Sell |
-49,335
| Closed | -$4.32M | – | 2186 |
|
|
2020
Q3 | $4.32M | Sell |
49,335
-85,719
| -63% | -$8.07M | ﹤0.01% | 1382 |
|
|
2020
Q2 | $13.3M | Sell |
135,054
-975
| -0.7% | -$85.8K | 0.02% | 659 |
|
|
2020
Q1 | $10.4M | Buy |
136,029
+121,555
| +840% | +$10.4M | 0.01% | 594 |
|
|
2019
Q4 | $1.28M | Buy |
14,474
+14,379
| +15,136% | +$1.19M | ﹤0.01% | 1419 |
|
|
2019
Q3 | $7K | Sell |
95
-88,879
| -100% | -$6.09M | ﹤0.01% | 2187 |
|
|
2019
Q2 | $6.47M | Buy |
88,974
+69,903
| +367% | +$5.49M | 0.01% | 640 |
|
|
2019
Q1 | $1.54M | Sell |
19,071
-235,202
| -92% | -$19.2M | ﹤0.01% | 1092 |
|
|
2018
Q4 | $23.4M | Buy |
+254,273
| New | +$22.4M | 0.03% | 311 |
|
|
2018
Q3 | – | Sell |
-570
| Closed | -$54.1K | – | 2515 |
|
|
2018
Q2 | $53K | Sell |
570
-9,956
| -95% | -$972K | ﹤0.01% | 1573 |
|
|
2018
Q1 | $996K | Sell |
10,526
-26,714
| -72% | -$2.93M | ﹤0.01% | 962 |
|
|
2017
Q4 | $3.6M | Buy |
+37,240
| New | +$3.51M | ﹤0.01% | 715 |
|
|
2017
Q2 | – | Sell |
-7,497
| Closed | -$504K | – | 2135 |
|
|
2017
Q1 | $489K | Buy |
+7,497
| New | +$471K | ﹤0.01% | 1493 |
|
|
2016
Q4 | – | Sell |
-2,238
| Closed | -$137K | – | 2962 |
|
|
2016
Q3 | $141K | Buy |
+2,238
| New | +$145K | ﹤0.01% | 1976 |
|
|
2016
Q1 | – | Sell |
-87,741
| Closed | -$4.89M | – | 2410 |
|
|
2015
Q4 | $5.2M | Buy |
87,741
+35,409
| +68% | +$2.04M | 0.01% | 670 |
|
|
2015
Q3 | $2.85M | Sell |
52,332
-52,170
| -50% | -$3.4M | 0.01% | 860 |
|
|
2015
Q2 | $7.02M | Sell |
104,502
-59,969
| -36% | -$3.92M | 0.01% | 603 |
|
|
2015
Q1 | $9.63M | Buy |
164,471
+13,205
| +9% | +$798K | 0.02% | 482 |
|
|
2014
Q4 | $9.9M | Buy |
151,266
+84,116
| +125% | +$5.3M | 0.03% | 469 |
|
|
2014
Q3 | $3.88M | Buy |
+67,150
| New | +$3.73M | 0.01% | 821 |
|
|
2014
Q1 | – | Sell |
-103,701
| Closed | -$5.48M | – | 3330 |
|
|
2013
Q4 | $5.48M | Buy |
+103,701
| New | +$5.1M | 0.03% | 413 |
|
Other funds holding ABBV
Parallax Volatility Advisers's ABBV Position: Q2 2026 in Review
Parallax Volatility Advisers reduced its AbbVie (ABBV) stake by 78% in Q2 2026, selling an estimated $2.8M and leaving 3,654 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #979.
Parallax Volatility Advisers first reported a position in ABBV in Q4 2013 and has held it in 33 quarters since. The position peaked at $23.4M in Q4 2018. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Parallax Volatility Advisers held 3,654 shares of AbbVie worth $919K as of Q2 2026.
- Parallax Volatility Advisers sold 13,032 AbbVie shares in Q2 2026, an estimated $2.8M.
- AbbVie made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #979 holding.
- Parallax Volatility Advisers first reported a position in AbbVie in Q4 2013 and has held it in 33 quarters since.
- Parallax Volatility Advisers's AbbVie position peaked at $23.4M in Q4 2018.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.